Center for Excellence in Drug Safety and Pharmacovigilance

PV Publication Updates

 

 

 

 

 

CEDSPV is your one stop source for information on the lastest drug safety, pharmacovigilance, and pharmacoepidemiology publications.  Here you can find monthly updates on the most recent DS &PV publications from a vast array of journals.  Stay up to date on the most recent methods of approaching drug safety challenges with cutting edge risk management strategies.

Something new on the Publication Updates horizon that we’ve left out ? Drop us a note at Team@CEDSPV.Com and we’ll be on it right away.

Pharmacovigilance Publications November 2012

Active pharmacovigilance and healthcare utilization.

Haas JS, Klinger E, Marinacci LX, Brawarsky P, Orav EJ, Schiff GD, Bates DW.

Am J Manag Care. 2012 Nov 1;18(11):e372-7.

Factors associated with spontaneous reporting of adverse drug reactions in Japan.

Yamada T, Watanabe Y, Kusama M, Sugiyama Y, Ono S.

Pharmacoepidemiol Drug Saf. 2012 Nov 21. doi: 10.1002/pds.3378.

Canada clamps down on access to drug safety data.

Webster PC.

Lancet. 2012 Nov 24;380(9856):1805. No abstract available.

Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records.

Liu M, McPeek Hinz ER, Matheny ME, Denny JC, Schildcrout JS, Miller RA, Xu H.

J Am Med Inform Assoc. 2012 Nov 17

Cetuximab infusion reactions: French pharmacovigilance database analysis.

Grandvuillemin A, Disson-Dautriche A, Miremont-Salamé G, Fourrier-Reglat A, Sgro C; The Reseau des Centres Regionaux de Pharmacovigilance Francais.

J Oncol Pharm Pract. 2012 Nov 15

Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012.

Kay J, Feagan BG, Guirguis MS, Keystone EC, Klein AV, Lubiniecki AS, Mould DR, Nyarko KA, Ridgway AA, Trudeau ME, Wang J.

Biologicals. 2012 Nov;40(6):517-27. doi: 10.1016/j.biologicals.2012.09.010

Suicidal poisonings with methadone in France: results of a two year national survey by the Toxicovigilance network.

Glaizal M, Gazin V, Aymard I, Messina-Gourlot C, Richard N, Mallaret M, Saviuc P, de Haro L.

Clin Toxicol (Phila). 2012 Nov;50(9):841-6. doi: 10.3109/15563650.2012.731510.

Suspected herbal hepatotoxicity: The pharmacovigilance dilemma with disputed and obsolete evaluation methods.

Teschke R, Frenzel C, Schulze J, Eickhoff A.

Regul Toxicol Pharmacol. 2012 Nov;64(2):343-4. doi: 10.1016/j.yrtph.2012.06.010. Epub 2012 Jun 23.